{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T03:57:20Z","timestamp":1769659040463,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11596-015-1476-4","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T01:16:14Z","timestamp":1438218974000},"page":"591-599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["BRAFV600E mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Yu-jia","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-ling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"issue":"1","key":"1476_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin, 2004,54(1):8\u201329","journal-title":"CA Cancer J Clin"},{"key":"1476_CR2","first-page":"48","volume-title":"World Health Organization classification of tumours: pathology and genetics of tumours of the endocrine organs","author":"R Lloyd","year":"2004","unstructured":"Lloyd R, De Lellis R, Heitz P, et al. World Health Organization classification of tumours: pathology and genetics of tumours of the endocrine organs. Lyon, France: IARC Press International Agency for Research on Cancer, 2004,48\u2013106"},{"key":"1476_CR3","first-page":"31","volume-title":"Cancer","author":"SM Chow","year":"2003","unstructured":"Chow SM, Law SC, Chan JK, et al. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003(98):31\u201340"},{"key":"1476_CR4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jso.20746","volume":"95","author":"C Cappelli","year":"2007","unstructured":"Cappelli C, Castellano M, Braga M, et al. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol, 2007,95:555\u2013560","journal-title":"J Surg Oncol"},{"key":"1476_CR5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/00016480410022822","volume":"125","author":"MJ Liou","year":"2005","unstructured":"Liou MJ, Lin JD, Chung MH, et al. Renal metastasis from papillary thyroid microcarcinoma. Acta Otolaryngol, 2005,125:438\u2013442","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"1476_CR6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/thy.2008.0185","volume":"19","author":"N Arora","year":"2009","unstructured":"Arora N, Turbendian HK, Kato MA, et al. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid, 2009,19(5):473\u2013477","journal-title":"Thyroid"},{"key":"1476_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1477-7819-11-291","volume":"1199","author":"SY Choi","year":"2013","unstructured":"Choi SY, Park HS, Kang MK, et al. The relationship between the BRAFV600E mutation in papillary thyroid microcarcinoma and clinicopathologic factors. World J Surg Oncol, 2013,1199:291\u2013295","journal-title":"World J Surg Oncol"},{"key":"1476_CR8","volume-title":"Clinical and biological characteristics of papillary thyroid microcarcinoma and the association with BRAF mutation","author":"YF Ji","year":"2008","unstructured":"Ji YF. Clinical and biological characteristics of papillary thyroid microcarcinoma and the association with BRAF mutation. Shanghai: Thesis of Nankai University, 2008"},{"issue":"5","key":"1476_CR9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2265.2005.02389.x","volume":"63","author":"TY Kim","year":"2005","unstructured":"Kim TY, Kim WB, Song JY, et al. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol, 2005,63(5):588\u2013593","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1476_CR10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1148\/radiol.2533090471","volume":"253","author":"JY Kwak","year":"2009","unstructured":"Kwak JY, Kim EY, Chung WY, et al. Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma. Radiology, 2009,253(3):854\u2013860","journal-title":"Radiology"},{"issue":"2","key":"1476_CR11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1245\/s10434-008-0233-3","volume":"16","author":"XL Lee","year":"2009","unstructured":"Lee XL, Gao M, Ji YF, et al. Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma. Ann Surg Oncol, 2009,16(2):240\u2013245","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1476_CR12","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1245\/s10434-010-1129-6","volume":"17","author":"KL Lin","year":"2010","unstructured":"Lin KL, Wang OC, Zhang XH, et al. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann Surg Oncol, 2010,17(12):3294\u20133300","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1476_CR13","first-page":"291","volume":"121","author":"ED Rossi","year":"2013","unstructured":"Rossi ED, Martini M, Capodimonti S, et al. BRAF(V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. Cancer, 2013,121(6):291\u2013297","journal-title":"Cancer"},{"issue":"1","key":"1476_CR14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/modpathol.2012.152","volume":"26","author":"RK Virk","year":"2013","unstructured":"Virk RK, Dyke ALV, Finkelstein A, et al. BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Mod Pathol, 2013,26(1):62\u201370","journal-title":"Mod Pathol"},{"issue":"6","key":"1476_CR15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cen.12386","volume":"80","author":"A Walczyk","year":"2014","unstructured":"Walczyk A, Kowalska A, Kowalik A, et al. The BRAFV600E mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome? Clin Endocrinol, 2014,80(6):899\u2013904","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1476_CR16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00268-011-1383-1","volume":"36","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Lee KE, Myong JP, et al. BRAFV600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J Surg, 2012,36(2):310\u2013317","journal-title":"World J Surg"},{"issue":"12","key":"1476_CR17","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.2012-2104","volume":"97","author":"C Li","year":"2012","unstructured":"Li C, Lee KC, Schneider EB, et al. BRAFV600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis. J ClinEndocrinolMetab, 2012,97(12):4559\u20134570","journal-title":"J ClinEndocrinolMetab"},{"issue":"1","key":"1476_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/cncr.22754","volume":"110","author":"JH Lee","year":"2007","unstructured":"Lee JH, Lee ES, Kim YS. Clinicopathologic significance of BRAFV600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer, 2007,110(1):38\u201346","journal-title":"Cancer"},{"issue":"5","key":"1476_CR19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MD.0b013e31826a9c71","volume":"91","author":"RP Tufano","year":"2012","unstructured":"Tufano RP, Teixeira GV, Bishop J, et al. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis. Medicine, 2012,91(5):274\u2013286","journal-title":"Medicine"},{"issue":"7","key":"1476_CR20","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/cncr.26500","volume":"118","author":"TH Kim","year":"2012","unstructured":"Kim TH, Park YJ, Lim JA, et al. The association of the BRAF (V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer, 2012,118(7):1764\u20131773","journal-title":"Cancer"},{"issue":"9270","key":"1476_CR21","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(00)04934-5","volume":"357","author":"M Clarke","year":"2001","unstructured":"Clarke M, Horton R. Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet, 2001,357(9270):1728","journal-title":"Lancet"},{"issue":"11","key":"1476_CR22","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2007-1179","volume":"92","author":"C Lupi","year":"2007","unstructured":"Lupi C, Giannini R, Ugolini C, et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab, 2007,92(11):4085\u20134090","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1476_CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/ERC-07-0212","volume":"15","author":"F Frasca","year":"2008","unstructured":"Frasca F, Nucera C, Pellegriti G, et al. BRAFV600E mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer, 2008,15(6):191\u2013205","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"1476_CR24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/his.12233","volume":"63","author":"Z Mussazhanova","year":"2013","unstructured":"Mussazhanova Z, Matsuda K, Naruke Y, et al. Significance of p53-binding protein 1 (53BP1) expression in thyroid papillary microcarcinoma: association with BRAFV600E mutation status. Histopathology, 2013,63(5):726\u2013734","journal-title":"Histopathology"},{"issue":"2","key":"1476_CR25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12020-012-9651-x","volume":"42","author":"N Kurtulmus","year":"2012","unstructured":"Kurtulmus N, Duren M, Ince U, et al. BRAFV600E mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. Endocrine, 2012,42(2):404\u2013410","journal-title":"Endocrine"},{"issue":"3","key":"1476_CR26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/thy.2011.0107","volume":"22","author":"I Marchetti","year":"2012","unstructured":"Marchetti I, Iervasi G, Mazzanti CM, et al. Detection of the BRAFV600E mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis. Thyroid, 2012,22(3):292\u2013298","journal-title":"Thyroid"},{"issue":"3","key":"1476_CR27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000343617","volume":"57","author":"SY Chung","year":"2013","unstructured":"Chung SY, Lee JS, Lee H, et al. Cytomorphological factors and braf mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma. Acta Cytol, 2013,57(3):252\u2013258","journal-title":"Acta Cytol"},{"issue":"8","key":"1476_CR28","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/modpathol.2010.116","volume":"23","author":"CK Jung","year":"2010","unstructured":"Jung CK, Kang YG, Bae JS, et al. Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma. Mod Pathol, 2010,23(8):1201\u20131208","journal-title":"Mod Pathol"},{"issue":"6","key":"1476_CR29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/modpathol.2008.51","volume":"21","author":"HS Min","year":"2008","unstructured":"Min HS, Choe G, Kim SW, et al. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid. Mod Pathol, 2008,21(6):748\u2013755","journal-title":"Mod Pathol"},{"issue":"6","key":"1476_CR30","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/cncr.22912","volume":"110","author":"V Rodolico","year":"2007","unstructured":"Rodolico V, Cabibi D, Pizzolanti G, et al. BRAFV600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid or 1 cm and their paired lymph node metastases. Cancer, 2007,110(6):1218\u20131226","journal-title":"Cancer"},{"issue":"1","key":"1476_CR31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1897-4287-10-10","volume":"10","author":"HJ Schulten","year":"2012","unstructured":"Schulten HJ, Salama S, Al-Mansouri Z, et al. BRAF mutations in thyroid tumors from an ethnically diverse group. Hered Cancer Clin Pract, 2012,10(1):10","journal-title":"Hered Cancer Clin Pract"},{"issue":"5","key":"1476_CR32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00268-007-9453-0","volume":"32","author":"S Noguchi","year":"2008","unstructured":"Noguchi S, Yamashita H, Uchino S, et al. Papillary microcarcinoma. World J Surg, 2008,32(5):747\u2013753","journal-title":"World J Surg"},{"issue":"2","key":"1476_CR33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/erc.1.0978","volume":"12","author":"M Xing","year":"2005","unstructured":"Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer, 2005,12(2):245\u2013262","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"1476_CR34","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/SLA.0b013e318148563d","volume":"246","author":"E Kebebew","year":"2007","unstructured":"Kebebew E, Weng J, Bauer J, et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg, 2007,246(3):466\u2013470","journal-title":"Ann Surg"},{"issue":"15","key":"1476_CR35","first-page":"4561","volume":"63","author":"X Xu","year":"2003","unstructured":"Xu X, Quiros RM, Gattuso P, et al. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res, 2003,63(15):4561\u20134567","journal-title":"Cancer Res"},{"issue":"6","key":"1476_CR36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1507\/endocrj.EJ12-0013","volume":"59","author":"Y Ito","year":"2012","unstructured":"Ito Y, Fukushima M, Kihara M, et al. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size. Endocr J, 2012,59(6):457\u2013464","journal-title":"Endocr J"},{"issue":"8","key":"1476_CR37","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/1097-0142(19871015)60:8<1767::AID-CNCR2820600816>3.0.CO;2-P","volume":"60","author":"N Kasai","year":"1987","unstructured":"Kasai N, Sakamoto A. New subgrouping of small thyroid carcinomas. Cancer, 1987,60(8):1767\u20131770","journal-title":"Cancer"},{"issue":"2","key":"1476_CR38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1749-4486.2010.02085.x","volume":"35","author":"D Giordano","year":"2010","unstructured":"Giordano D, Gradoni P, Oretti G, et al. Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol, 2010,35(2):118\u2013124","journal-title":"Clin Otolaryngol"},{"issue":"8","key":"1476_CR39","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1210\/jc.2010-0698","volume":"95","author":"V Bernet","year":"2010","unstructured":"Bernet V. Approach to the patient with incidental papillary microcarcinoma. J ClinEndocrinol Metab, 2010,95(8):3586\u20133592","journal-title":"J ClinEndocrinol Metab"},{"issue":"32","key":"1476_CR40","first-page":"191","volume":"46","author":"XM Yu","year":"2012","unstructured":"Yu XM, Lloyd R, Chen H. Current treatment of papillary thyroid microcarcinoma. Adv Surg, 2012,46(32):191\u2013203","journal-title":"Adv Surg"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-015-1476-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1476-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T07:53:23Z","timestamp":1718006003000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-015-1476-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1476"],"URL":"https:\/\/doi.org\/10.1007\/s11596-015-1476-4","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}